Reduction in Clinical and Economic Burden by Treating All Medicaid Patients With Chronic Hepatitis C (CHC): A Decision-Analytic Model

被引：0
|
作者：
Younossi, Zobair M.
Gordon, Stuart C.
Ahmed, Aijaz
Dieterich, Douglas
Saab, Sammy
Beckerman, Rachel
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)32245-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1168
引用
收藏
页码：S656 / S657
页数：2
相关论文
共 50 条
  • [1] Economic Burden Of Chronic Hepatitis C (CHC) In Medicaid And Commercially Insured Patients In The United States
    Nwankwo, Chizoba
    Corman, Shelby L.
    Liu, Jinan
    [J]. HEPATOLOGY, 2017, 66 : 539A - 539A
  • [2] Treating Medicaid Patients With Hepatitis C: Clinical and Economic Impact
    Younossi, Zobair
    Gordon, Stuart C.
    Ahmed, Aijaz
    Dieterich, Douglas
    Saab, Sammy
    Beckerman, Rachel
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2017, 23 (02): : 107 - +
  • [3] Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence
    Nuño Solinís R.
    Arratibel Ugarte P.
    Rojo A.
    Sanchez Gonzalez Y.
    [J]. Infectious Diseases and Therapy, 2016, 5 (4) : 491 - 508
  • [4] The health impact of delaying direct-acting antiviral treatment for chronic hepatitis C: A decision-analytic approach
    Erman, Aysegul
    Wong, William W. L.
    Feld, Jordan J.
    Grootendorst, Paul
    Krahn, Murray D.
    [J]. LIVER INTERNATIONAL, 2020, 40 (01) : 51 - 59
  • [5] RESOURCE UTILIZATION AND DIRECT MEDICAL COST OF CHRONIC HEPATITIS C (CHC) IN THAILAND: A HEAVY BUT MANAGEABLE ECONOMIC BURDEN
    Thongsawat, S.
    Piratvisuth, T.
    Pramoolsinsap, C.
    Chutaputti, A.
    Tanwandee, T.
    Sukarom, I
    Tinmanee, S.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A348 - A348
  • [6] Intelligence platform for chronic hepatitis C (CHC): Model of the disease and prediction of clinical outcome
    Trapero-Marugan, M.
    Marin, M.
    Salcedo-Mora, X.
    del Rio, J. M.
    Pivel, J. P.
    Moreno-Otero, R.
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 : S247 - S247
  • [7] Occult HBV infection in patients with chronic hepatitis C (CHC): Frequency and clinical impact
    Fabris, P
    Brown, D
    Tositti, G
    Bozzola, L
    Giordani, MT
    de Lalla, F
    Woong, C
    Dusheiko, GM
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 142 - 142
  • [8] A Decision-Analytic Markov Model To Evaluate The Health Outcomes of Ledipasvir/Sofosbuvir (LDV/SOF) for Patients with Chronic Hepatitis C (HCV) Genotype 1 (GT1) Infection
    Younossi, Zobair
    Saab, Sammy
    Ahmed, Aijaz
    Gordon, Stuart C.
    [J]. HEPATOLOGY, 2014, 60 : 1043A - 1043A
  • [9] TREATMENT BURDEN ASSOCIATED WITH PEGINTERFERON- BASED ANTIVIRAL THERAPY FOR PATIENTS WITH CHRONIC HEPATITIS C (CHC) IN JAPAN
    Kuwabara, H.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A98 - A99
  • [10] THE ECONOMIC BURDEN OF ADVANCED LIVER DISEASE AMONG PATIENTS WITH HEPATITIS C VIRUS: A STATE MEDICAID PERSPECTIVE
    Menzin, J.
    White, L. A.
    Nichols, C.
    Deniz, B.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A181 - A181
12345